Precision Approaches in Radiation Synthetic Combinations (PAIRS, RP1 Clinical Trial Optional)
National Institutes of Health · Department of Health and Human Services
At a glance
Precision Approaches in Radiation Synthetic Combinations (PAIRS, RP1 Clinical Trial Optional) is a forecasted federal grant opportunity from the National Institutes of Health (Department of Health and Human Services). The agency's forecast estimates an application due date of November 11, 2026; forecast dates can change. Applicant types listed as eligible include state governments, county governments, city or township governments, special district governments, independent school districts and 10 more. Cost sharing is not required. It is funded under Assistance Listing 93.395 (Cancer Treatment Research).
Summary assembled from the official notice's fields. The official notice governs.
Key facts
- Mar 3, 2026Forecast posted
- Jun 1, 2026 (est.)Full notice expected
- Nov 11, 2026 (est.)Application deadlinenext date
- Jul 1, 2027 (est.)Est. award date
- Posted
- Mar 3, 2026
- Est. close date
- Nov 11, 2026
- Est. award date
- Jul 1, 2027
- Award floor
- Not specified
- Award ceiling
- Not specified
- Est. total funding
- Not specified
- Expected awards
- Not specified
- Cost sharing
- Not required
- Funding instrument
- Grant
- Opportunity category
- Discretionary
- Fiscal year
- FY2027
Typical awards for this program (SAM.gov listing for ALN 93.395, not this notice): Range: $5,000 to $22,055,360 Average: $653,665
Who can apply
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public colleges & universities
- Federally recognized tribal governments
- Public & Indian housing authorities
- Native American tribal organizations
- 501(c)(3) nonprofits
- Nonprofits without 501(c)(3) status
- Private colleges & universities
- For-profit organizations (not small businesses)
- Small businesses
- Others (see notice)
Additional information on eligibility (from the notice)
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
A quick check against the listed applicant types — other requirements in the notice still apply.
Based on the published notice. Review the official notice for complete eligibility requirements.
What it funds
Official synopsis as published by the agency, formatted for readability.
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits research projects that investigate actionable synthetic vulnerabilities that can be conditionally paired with tumor responses to radiation therapy. The goal of the Precision Approaches in Radiation Synthetic Combinations (PAIRS) program is to develop radiation-synthetic combination strategies and facilitate their adoption into the precision medicine toolkit toward building new and effective anticancer treatments. Early synthetic lethality–based therapeutic strategies in oncology primarily focused on targeting fixed mutations or genomic abnormalities. More recently, however, it has become clear that clinical benefit is often determined by context-dependent vulnerabilities arising from the intrinsic mutational landscape and adaptive tumor responses.
This NOFO is unique in its scope, supporting innovative cancer therapy strategies that explicitly exploit context-dependent effects of radiation therapy (RT) using drug-radiation combinations. The central premise of the PAIRS is that these conditional RT-induced responses can be leveraged to create or enhance actionable vulnerabilities that synergize with molecularly targeted agents for better outcomes. A defining feature of PAIRS is its emphasis on precision, scientific rigor, and reproducibility, aligned with NIH’s scientific priorities. Radiation effects are clinically titratable through advances in delivery accuracy and flexibility, including dose, schedule, and spatial targeting. These capabilities enable the rational design of conditional RT-synthetic combination strategies that preferentially exploit tumor-specific essentialities while sparing normal tissues, thereby enhancing the therapeutic index by optimizing biological response. This NOFO consolidates the prior exploratory/developmental and research project funding opportunities to streamline the application process and maintain momentum in developing approaches that target actionable vulnerabilities within the defined radiation research scope. The applicants may submit either for exploratory/developmental research projects with a project period of up to 2 years or for research projects with a project period of 4 to 5 years.
How to apply
0 of 7 done · progress saved in this browser
Assistance Listing
What is an ALN?Reported obligations under ALN 93.395
Historical data · not a predictionAgency contact (as published)
NCI PAIRS Program
Telephone: 240-276-5703
Quick answers
Is this opportunity open for applications yet?
Not yet. It is a forecast — an agency's advance notice of an expected opportunity. The agency estimates posting the full notice around June 1, 2026. Forecast details and dates can change.
Who is eligible to apply for this opportunity?
The official notice lists these applicant types as eligible: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public colleges & universities, Federally recognized tribal governments, Public & Indian housing authorities, Native American tribal organizations, 501(c)(3) nonprofits, Nonprofits without 501(c)(3) status, Private colleges & universities and 3 more. Additional restrictions may apply; review the full notice.
How do I apply for this opportunity?
Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity PAR-26-152), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.
Related open opportunities
Matched on shared Assistance Listings, agency, categories and eligible applicant types.
Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE, RP1 Clinical Trial Not Allowed)
National Institutes of Health- Award range
- Amount not specified
- Est. close
- Oct 5, 2026 (est.)
- Who can apply
- State governments, County governments, City or township governments and 12 more
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
National Institutes of Health- Award range
- Up to $500K
- Closes
- Jan 7, 2027
- Who can apply
- State governments, County governments, City or township governments and 12 more
Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
National Institutes of Health- Award range
- Up to $700K
- Closes
- Jan 11, 2027
- Who can apply
- State governments, County governments, City or township governments and 12 more
Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required)
National Institutes of Health- Award range
- Amount not specified
- Est. close
- Jan 25, 2027 (est.)
- Who can apply
- State governments, County governments, City or township governments and 12 more
Canine Cancer Immunotherapy Network (K9CIN; U01 Clinical Trial Not Allowed)
National Institutes of Health- Award range
- Amount not specified
- Est. close
- Jan 25, 2027 (est.)
- Who can apply
- State governments, County governments, City or township governments and 12 more
Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)
National Institutes of Health- Award range
- Up to $500K
- Closes
- Jul 5, 2029
- Who can apply
- State governments, County governments, City or township governments and 12 more